Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Myeloid cell-derived creatine in the hypoxic niche promotes glioblastoma growth

Cell Metabolism(2023)10.1016/j.cmet.2023.11.013Source: DataRank Database

Myeloid cell-derived creatine in the hypoxic niche promotes glioblastoma growth is a research paper published in Cell Metabolism (2023). On theSindex it has a DataRank of 0. It has been cited 61 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access61 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)Impact (FWCI 6.60)OA: bronzeTopics (39)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (34)

Leah K. Billingham,Andrew Zolp,Tzu-Yi Chia,Caylee Silvers,Joshua L. Katz ORCID

Live enrichment

PubMed:38134929 OpenAlex:https://openalex.org/W4390063976

NINDS

Grant: 1R01NS115955-01

NINDS

Grant: / R01NS096376-06A1

National Cancer Institute

Grant: CA060553

National Cancer Institute

Grant: 1R01CA223547-01

National Cancer Institute

Grant: R35CA197532

National Cancer Institute

Grant: 1R01CA279686-01

National Cancer Institute

Grant: P50CA221747

National Cancer Institute

Grant: RGX-202-01

NCI NIH HHS

Grant: R01 CA279686

NCI NIH HHS

Grant: T32 CA070085

NCI NIH HHS

Grant: P30 CA060553

NINDS NIH HHS

Grant: R01 NS115955

NCI NIH HHS

Grant: R37 CA258426

FWCI

6.60

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.cell.com/article/S155041312300445X/pdf

publisherhttp://www.cell.com/article/S155041312300445X/pdf

publisherhttps://api.elsevier.com/content/article/PII:S155041312300445X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S155041312300445X?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.cmet.2023.11.013

Fields of Study

Cancer, Hypoxia, and MetabolismMetabolomics and Mass Spectrometry StudiesAdipose Tissue and MetabolismMiceAnimalsHumansGlioblastomaCreatineHypoxiaMyeloid CellsMyeloid Progenitor CellsCell Line, Tumor

MeSH Terms

AnimalsHypoxiaCreatineGlioblastomaHumansMyeloid CellsMyeloid Progenitor CellsCell Line, TumorMice

Keywords

CreatineBiologyMyeloidHypoxia (environmental)Cancer researchPhenotypeTumor hypoxiaInternal medicineEndocrinologyMedicineBiochemistryRadiation therapyChemistryGenecreatine metabolismglioblastomamyeloid cellspseudopalisading necrosis

Sustainable Development Goals

SDG 0: Good health and well-being